Combinations of susceptible genotypes and individual responses to toxicants

Environmental Health Perspectives

Volumn 105, Issue SUPPL. 4, 1997, Pages 755-758

  Hirvonen, Ari ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

CYP1A1; CYP2D6; CYP2E1; Genetic polymorphisms; GSTM1; GSTT1; NAT1; NAT2

Indexed keywords

TOXIC SUBSTANCE;

CANCER; CONFERENCE PAPER; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; GENOTYPE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030875335     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.97105s4755     Document Type: Conference Paper

References (48)

1. Idle JR. Is environmental carcinogenesis modulated by host polymorphism? Mutat Res 24:259-266 (1991).
2. Nebert DW. Role of genetics and drug metabolism in human cancer risk. Mutat Res 247:267-281 (1991).
3. Harris CC. Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res Suppl 51:5023s-5044s (1991).
4. Hirvonen A. Genetic factors in individual responses to environmental exposures. J Occup Environ Med 37:37-43 (1995).
5. Smith CAD. Debrisoquine hydroxylase polymorphism and susceptibility to Parkinson's disease. Lancet 339:1375-1377 (1992).
6. Armstrong M, Daly AK, Cholerton S, Bateman DN, Idle JR. Mutant debrisoquine hydroxylase genes in Parkinson's disease. Lancet 339:1017,1018 (1992).
7. Borlak J, Harsany V, Schneble H, Haegele KD. pNAT and CYP2D6 gene polymorphism in epileptic patients. Biochem Pharmacol 48:1717-1720 (1994).
8. Iwahashi K. CYP2D6 genotype and possible susceptibility to the neuroleptic malignant syndrome. Biol Psychiatry 36:780-782 (1994).
9. Seidegård J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Nad Acad Sci USA 85:7293-7297 (1988).
10. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300:271-276 (1994).
11. Zhong S, Wyllie H, Barnes D, Wolf CR, Spurr NK. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14:1821-1824 (1993).
12. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Vainio H. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 14:1479-1481 (1993).
13. Bell D, Taylor JA, Paulson D, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen metabolism gene glutathione S-transferase M1 (GSTM1) increases susceptibility to bladder cancer. J Natl Cancer Inst 85:1159-1164 (1993).
14. Lafuente A, Pujol F, Carreterro P, Villa JP, Cuchi A. Human glutathione S-transferase μ (GSTμ) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett 68:49-54 (1993).
15. Elexpuru-Camiruaga J, Buxton N, Kandula V, Pilatha SD, Campbell D, McIntosh J, Broome J, Jones P, Inskip A, Alldersea J et al. Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci. Cancer Res 554:237-4239 (1995).
16. Chen H, Sandler DP, Taylor JA, Shore DL, Liu E, Bloomfield CD, Bell DA. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 347:295-297 (1996).
17. Evans DAP. N-Acetyltransferase. Pharmacol Ther 42:157-234 (1989).
18. Kadlubar FF, Butler MA, Kaderlik KR, Chou HC, Lang NP. Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. Environ Health Perspect 98:69-74 (1992).
19. Hein DW. Acetylator genotype and arylamine-induced carcinogenesis. Biochem Biophys Acta 948:37-66 (1988).
20. Ladero JM, Gonzalez JF, Benitez J, Vargas E, Fernandez MJ, Baki W, Diaz-Rubio M. Acetylator polymorphism in human colorectal carcinoma. Cancer Res 51:2098-2100 (1991).
21. Hayesh RB, Bi W, Rothman N, Broly F, Caporaso N, Feng P, You X, Yin S, Woosley RL, Meyer UA. N-Acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers. Carcinogenesis 14:675-678 (1993).
22. Nebert DW, Weber WW. Pharmacogenetics. In: Principles of Drug Action. The Basis of Pharmacology (Pratt WB, Taylor P, eds). New York:Churchill Livingstone, 1990; 469-531.
23. Vineis P, Bartsch H, Caporaso N, Harrington AM, Kadlubar FF, Landi MT, Malaveille C, Shields P, Skipper P, Talaska G et al. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 369:154-156 (1994).
24. Blum M, Grant DM, McBride W, Heim M, Meyer UA. Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol 9:193-203 (1990).
25. Oshako S, Deguchi T. Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver. J Biol Chem 265:4630-4634 (1990).
26. Blum M, Demierre A, Grant DM, Heim M, Meyer UA. Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc Natl Acad Sci USA 88:5237-5241 (1991).
27. Vatsis KP, Weber WW. Structural heterogeneity of Caucasian N-acetyltransferase at the NAT1 gene locus. Arch Biochem Biophys 301:71-76 (1993).
28. Bell DA, Badavi A, Lang N, Ilett KF, Kadlubar FF, Hirvonen A. Polymorphism in the NAT1 polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue samples. Cancer Res 55:5226-5229 (1995).
29. Fredrickson SM, Messing EM, Reznikoff CA, Swaminathan S. Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells. Cancer Epidemiol Biomarkers Prev 3:25-32 (1994).
30. Bell DA, Stephens DA, Castranio T, Umbach DM, Watson M, Deakin M, Elder J, Hendrickse C, Duncan H, Strange RC. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res 55:3537-3542 (1995).
31. Hayashi SI, Watanabe J, Nakachi K, Kawajiri K. Genetic linkage of lung cancer-associated Msp I polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J Biochem 110:407-411 (1991).
32. Alexandrie A-K, Sundberg MI, Seidegård J, Seidegård J, Törnling G, Rannug A. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis 15:1785-1790 (1994).
33. Nakachi K, Imai K, Hayashi S, Kawajiri K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in Japanese population. Cancer Res 53:2994-2999 (1993).
34. Anttila S, Hirvonen A, Husgafvel-Pursiainen K, Karjalainen A, Nurminen T, Vainio H. Combined effect of CYP1A1 inducibility and GSTM1 polymorphism on histological type of lung cancer. Carcinogenesis 15:1133-1135 (1994).
35. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JR, Brasure JR, Laughlin R, Nemoto T, Michalek AM, Harrington A et al. Cytochrome P450 1A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res 55:3483-3485 (1995).
36. Vaury C, Laine R, Noguiez P, de Coppet P, Jaulin C, Praz F, Pompon D, Amor-Gueret M. Human glutathione S-transferase M1 null genotype is associated with a high inducibility of cytochrome P450 1A1 gene transcription. Cancer Res 55:5520-5523 (1995).
37. Hirvonen A, Pelin K, Tammilehto L, Karjalainen A, Mattson K, Linnainmaa K. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers for asbestos-associated human malignant mesothelioma. Cancer Res 55:2981-2983 (1995).
38. Warwick A, Sarhanis P, Redman C, Pemble S, Taylor JB, Ketterer B, Jones P, Alldersea J, Gilford J, Yengi L et al. Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1, CYP2D6 and smoking. Carcinogenesis 15:2841-2845 (1994).
39. Perrett CW, Clayton RN, Pistorello M, Boscaro M, Scanari M, Bates AS, Buckley N, Jones P, Fryer A, Gilford J et al. GSTM1 and CYP2D6 genotype frequencies in patients with pituitary tumours: effects on p53, ras and gsp. Carcinogenesis 16:1643-1645 (1995).
40. Duncan H, Swan C, Green J, Jones P, Brannigan K, Alldersea J, Fryer A, Strange RC. Susceptibility to ulcerative colitis and Crohn's disease: interactions between glutathione S-transferase GSTM1 and GSTT1 genotypes. Clin Chim Acta 240:53-61 (1995).
41. Yu M-W, Gladek-Yarborough A, Chiampraset S, Santella RM, Liaw Y-F, Chen C-J. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology 109:1266-1273 (1995).
42. Rothman N, Shields PG, Poirier MC, Harrington AM, Ford DP, Strickland PT. The impact of glutathione S-transferase M1 and cytochrome P450 1A1 genotypes on white-blood-cell polycyclic aromatic hydrocarbon-DNA adduct levels in humans. Mol Carcinog 14:63-68 (1995).
43. Carsten U, Alexandrie A-K, Högstedt B, Rannug A, Bratt I, Hagmar L. B- and T-lymphocyte micronuclei in chimney sweeps with respect to genetic polymorphisms for CYP1A1 and GST1 (class Mu). Mutat Res 289:187-195 (1993).
44. Ichiba M, Hagmar L, Rannug A, Högstedt B, Alexandrie A-K, Carstensen U, Hemminki K. Aromatic DNA adducts, micronuclei and genetic polymorphisms for CYP1A1 and GST1 in chimney sweeps. Carcinogenesis 15:1347-1352 (1994).
45. Hou S-M, Lambert B, Hemminki K. Relationship between hprt mutant frequency, aromatic DNA adducts and genotypes for GSTM1 and NAT2 in bus maintenance workers Carcinogenesis 16:1913-1917 (1995).
46. Norppa H, Pelin K, Järventaus H, Ollikainen T, Knudsen L, Okkels H, Scarpato R, Migliore L, Hirvonen A. Polymorphisms of xenobiotic-metabolizing enzymes: influence on cytogenetic parameters in vitro and in vivo. Abstract. Nordtox/NordEMS-96: The 4th Nordic Toxicology Meeting, 27-31 March 1996, Storlien, Sweden.
47. Yu MC, Ross RK, Chan K, Henderson BE, Skipper PL, Tannenbaum SR, Goetzee GA. Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black, and asian smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 4:861-864 (1995).
48. Badavi A, Hirvonen A, Bell DA, Lang N, Kadlubar FF. Role of aromatic amine acetyltransferases NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res 55:5230-5237 (1995).